Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations

Objective: Due to a lack of effective therapy, triple-negative breast cancer (TNBC) is extremely poor prognosis. Metabolic reprogramming is an important hallmark in tumorigenesis, cancer diagnosis, prognosis, and treatment. Categorizing metabolic patterns in TNBC is critical to combat heterogeneity...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lijuan, Wu, Nan, Zhuang, Gaojian, Geng, Lin, Zeng, Yu, Wang, Xuan, Wang, Shuang, Ruan, Xianhui, Zheng, Xiangqian, Liu, Juntian, Gao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502304/
https://www.ncbi.nlm.nih.gov/pubmed/37719859
http://dx.doi.org/10.3389/fphar.2023.1224828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502304/
https://www.ncbi.nlm.nih.gov/pubmed/37719859
http://dx.doi.org/10.3389/fphar.2023.1224828

Ejemplares similares